Correlation Between ENCE Energa and Oryzon Genomics
Can any of the company-specific risk be diversified away by investing in both ENCE Energa and Oryzon Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ENCE Energa and Oryzon Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ENCE Energa y and Oryzon Genomics SA, you can compare the effects of market volatilities on ENCE Energa and Oryzon Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ENCE Energa with a short position of Oryzon Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ENCE Energa and Oryzon Genomics.
Diversification Opportunities for ENCE Energa and Oryzon Genomics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between ENCE and Oryzon is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding ENCE Energa y and Oryzon Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oryzon Genomics SA and ENCE Energa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ENCE Energa y are associated (or correlated) with Oryzon Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oryzon Genomics SA has no effect on the direction of ENCE Energa i.e., ENCE Energa and Oryzon Genomics go up and down completely randomly.
Pair Corralation between ENCE Energa and Oryzon Genomics
Assuming the 90 days trading horizon ENCE Energa y is expected to generate 0.94 times more return on investment than Oryzon Genomics. However, ENCE Energa y is 1.06 times less risky than Oryzon Genomics. It trades about 0.01 of its potential returns per unit of risk. Oryzon Genomics SA is currently generating about -0.27 per unit of risk. If you would invest 283.00 in ENCE Energa y on August 29, 2024 and sell it today you would earn a total of 0.00 from holding ENCE Energa y or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ENCE Energa y vs. Oryzon Genomics SA
Performance |
| Timeline |
| ENCE Energa y |
| Oryzon Genomics SA |
ENCE Energa and Oryzon Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ENCE Energa and Oryzon Genomics
The main advantage of trading using opposite ENCE Energa and Oryzon Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ENCE Energa position performs unexpectedly, Oryzon Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oryzon Genomics will offset losses from the drop in Oryzon Genomics' long position.| ENCE Energa vs. ACS Actividades de | ENCE Energa vs. ArcelorMittal SA | ENCE Energa vs. Mapfre | ENCE Energa vs. Ferrovial |
| Oryzon Genomics vs. ENCE Energa y | Oryzon Genomics vs. Viscofan | Oryzon Genomics vs. Vidrala SA | Oryzon Genomics vs. Ebro Foods |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |